The Distribution in Tissues and Urine of Arsenic Metabolites After Subchronic Exposure to Dimethylarsinic Acid (DMA V ) in Rats

Dimethylarsinic acid (DMA V ) acted as cancer promoter promoted urinary bladder, liver, and lung carcinogenesis in rats. Understanding of the distribution of arsenicals in critical sites will aid to define the action of DMA V -induced toxicity and carcinogenicity. The present experiment was conducted to compare the accumulated levels of arsenicals in the liver, kidney, and bladder of both male and female rats after subchronic exposure to DMA V . After exposure to DMA V in drinking water for 10 weeks, urinary DMA concentrations of 100 and 200 ppm DMA V –treated rats increased significantly compared with those of the control rats. Smaller amount of trimethylarsinic acid (TMA) was detected in urine, but not in liver, kidney, and bladder muscle. In the liver and kidney, the levels of DMA in DMA V -treated rats significantly increased compared with those of the control group, but there was no difference between 100 and 200 ppm DMA V –treated rats. DMA did not accumulate in bladder muscle. There was no difference for DMA concentrations between male and female rats. Our results suggest that the accumulation of DMA in the liver and kidney was saturated above 100 ppm DMA V treatment concentration, and DMA V was a little partly metabolized to TMA, and TMA was rapidly excreted into urine.